Page last updated: 2024-08-24

sulofenur and Lung Neoplasms

sulofenur has been researched along with Lung Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jung, SH; Kang, JS; Kim, HM; Kim, NS; Lee, KC; Sharma, VK; Subramanian, S; Thanigaimalai, P1
Einhorn, LH; Fossella, F; Lippman, SM; Munshi, NC; Seitz, DE1
Alberts, DS; Fossella, FV; Hardy, J; Haynes, TR; Lippman, SM; O'Brien, M; Seitz, DE; Taylor, CW; Wiltshaw, E; Wolen, RL1

Trials

2 trial(s) available for sulofenur and Lung Neoplasms

ArticleYear
Phase II study of sulofenur (LY 186641). A novel antineoplastic agent in advanced non-small cell lung cancer.
    Investigational new drugs, 1993, Volume: 11, Issue:1

    Topics: Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Drugs, Investigational; Female; Humans; Lung Neoplasms; Male; Middle Aged; Sulfonylurea Compounds

1993
Hypoprothrombinemia from coadministration of sulofenur (LY 186641) and warfarin: report of three cases.
    Investigational new drugs, 1991, Volume: 9, Issue:4

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Drug Interactions; Female; Humans; Hypoprothrombinemias; Lung Neoplasms; Middle Aged; Ovarian Neoplasms; Sulfonylurea Compounds; Warfarin

1991

Other Studies

1 other study(ies) available for sulofenur and Lung Neoplasms

ArticleYear
Structure--activity relationship studies of novel arylsulfonylimidazolidinones for their anticancer activity.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:8

    Topics: Animals; Antineoplastic Agents; Arylsulfonates; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; Doxorubicin; Drug Screening Assays, Antitumor; Female; Humans; Hydrophobic and Hydrophilic Interactions; Imidazolidines; Lung Neoplasms; Mice; Mice, Nude; Molecular Conformation; Neoplasm Transplantation; Ovarian Neoplasms; Structure-Activity Relationship

2011